Cossu M, Pau A, Turtas S, Viola C, Viale G L
Department of Neurosurgery, University of Genoa, Italy.
Neurosurgery. 1993 Mar;32(3):344-6; discussion 347. doi: 10.1227/00006123-199303000-00002.
Forty-seven patients, who underwent surgery over a 34-year period by the wrapping or coating of ruptured intracranial aneurysms, have been retrospectively evaluated. The following materials were used in the surgical procedures: muscle with gelatin sponge (7 cases), gauze (2 cases), oxidized cellulose with Biobond (28 cases), Histoacryl with gauze or fascia (10 cases). The patients were monitored for up to 37 years (mean, 13.7 +/- 8.2 yr). One or more subsequent bleedings occurred in eight patients (17%). Three patients had additional bleeding and died in the early postoperative phase (within 1 mo after surgery). In five patients, the subsequent bleeding occurred between 1 and 15 years postoperatively, with two fatalities. One patient experienced two recurrences. Therefore, the mortality rate for postoperative bleedings was 10.6% (five patients) in the whole series, and the incidence of early (within 1 mo after surgery) fatal bleedings was 6.4%. After the first month from the initial hemorrhage, the global risk of subsequent bleeding was 0.93%/yr. Among the nine patients whose aneurysms were wrapped with muscle, gelatin sponge, or gauze, four additional bleedings occurred, whereas four relapses were observed among the 38 cases treated by employing bioadhesive agents (P < 0.04; Fisher's exact test). The rate of further bleeding was higher (25%) in patients undergoing surgery in the premicrosurgical era compared with that (8.7%) recorded in patients treated by microsurgery (difference statistically not significant).
对47例在34年期间接受了破裂颅内动脉瘤包裹或涂层手术的患者进行了回顾性评估。手术过程中使用了以下材料:肌肉加明胶海绵(7例)、纱布(2例)、氧化纤维素加生物粘合剂(28例)、组织粘合剂加纱布或筋膜(10例)。对患者进行了长达37年的监测(平均13.7±8.2年)。8例患者(17%)发生了一次或多次后续出血。3例患者术后早期(术后1个月内)出现额外出血并死亡。5例患者在术后1至15年发生后续出血,其中2例死亡。1例患者经历了两次复发。因此,整个系列中术后出血的死亡率为10.6%(5例患者),早期(术后1个月内)致命出血的发生率为6.4%。在首次出血后的第一个月之后,后续出血的总体风险为0.93%/年。在9例用肌肉、明胶海绵或纱布包裹动脉瘤的患者中,发生了4次额外出血,而在38例采用生物粘合剂治疗的病例中观察到4例复发(P<0.04;Fisher精确检验)。与显微手术治疗的患者(8.7%)相比,显微手术前时代接受手术的患者进一步出血的发生率更高(25%)(差异无统计学意义)。